Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...